Guy Levy - Net Worth and Insider Trading

Guy Levy Net Worth

The estimated net worth of Guy Levy is at least $4 Million dollars as of 2024-05-25. Guy Levy is the Director of BioAtla Inc and owns about 2,247,524 shares of BioAtla Inc (BCAB) stock worth over $4 Million. Details can be seen in Guy Levy's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Guy Levy has not made any transactions after 2021-08-24 and currently still holds the listed stock(s).

Transaction Summary of Guy Levy

To

Guy Levy Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Guy Levy owns 2 companies in total, including Lyra Therapeutics Inc (LYRA) , and BioAtla Inc (BCAB) .

Click here to see the complete history of Guy Levy’s form 4 insider trades.

Insider Ownership Summary of Guy Levy

Ticker Comapny Transaction Date Type of Owner
LYRA Lyra Therapeutics Inc 2020-04-30 10 percent owner
BCAB BioAtla Inc 2021-08-24 director & 10 percent owner

Guy Levy Latest Holdings Summary

Guy Levy currently owns a total of 1 stock. Guy Levy owns 2,247,524 shares of BioAtla Inc (BCAB) as of August 24, 2021, with a value of $4 Million.

Latest Holdings of Guy Levy

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BCAB BioAtla Inc 2021-08-24 2,247,524 1.71 3,843,266

Holding Weightings of Guy Levy


Guy Levy Form 4 Trading Tracker

According to the SEC Form 4 filings, Guy Levy has made a total of 3 transactions in BioAtla Inc (BCAB) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in BioAtla Inc is the sale of 546,709 shares on August 24, 2021, which brought Guy Levy around $22 Million.

Insider Trading History of Guy Levy

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Guy Levy Trading Performance

GuruFocus tracks the stock performance after each of Guy Levy's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Guy Levy is 102.6%. GuruFocus also compares Guy Levy's trading performance to market benchmark return within the same time period. The performance of stocks bought by Guy Levy within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Guy Levy's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Guy Levy

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 29.66
Relative Return to S&P 500(%) 28.07

Guy Levy Ownership Network

Ownership Network List of Guy Levy

No Data

Ownership Network Relation of Guy Levy


Guy Levy Owned Company Details

What does Lyra Therapeutics Inc do?

Who are the key executives at Lyra Therapeutics Inc?

Guy Levy is the 10 percent owner of Lyra Therapeutics Inc. Other key executives at Lyra Therapeutics Inc include director & Executive Chair Harlan Waksal , 10 percent owner Nbvm Gp, Llc , and 10 percent owner Perceptive Life Sciences Master Fund Ltd .

Lyra Therapeutics Inc (LYRA) Insider Trades Summary

Over the past 18 months, Guy Levy made no insider transaction in Lyra Therapeutics Inc (LYRA). Other recent insider transactions involving Lyra Therapeutics Inc (LYRA) include a net purchase of 3,610,832 shares made by Perceptive Life Sciences Master Fund Ltd , a net purchase of 1,805,416 shares made by Nbvm Gp, Llc , and a net purchase of 1,805,416 shares made by Edward T Anderson .

In summary, during the past 3 months, insiders sold 0 shares of Lyra Therapeutics Inc (LYRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lyra Therapeutics Inc (LYRA) were sold and 7,246,664 shares were bought by its insiders, resulting in a net purchase of 7,246,664 shares.

Lyra Therapeutics Inc (LYRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Lyra Therapeutics Inc Insider Transactions

No Available Data

Guy Levy Mailing Address

Above is the net worth, insider trading, and ownership report for Guy Levy. You might contact Guy Levy via mailing address: C/o Soleus Private Equity Gp I, Llc, 104 Field Point Road, 2nd Floor, Greenwich Ct 06830.

Discussions on Guy Levy

No discussions yet.